Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-Alpha Therapy in Hepatocellular Carcinoma

International Journal of Biological Sciences - Canada
doi 10.7150/ijbs.6214
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ivyspring International Publisher

Related search

A Meta-Analysis and Systematic Review: Adjuvant Interferon Therapy for Patients With Viral Hepatitis-Related Hepatocellular Carcinoma

World Journal of Surgical Oncology
SurgeryOncology
2013English

Controversies of Hepatectomy and Adjuvant Therapy for Hepatocellular Carcinoma: Moving Forward

Hepatoma Research
2019English

Alpha-Interferon Therapy in a Patient With Renal Cell Carcinoma and Renal Hypofunction

Japanese Journal of Urology
Urology
1995English

Cost Effectiveness of Adjuvant Therapy for Hepatocellular Carcinoma During the Waiting List for Liver Transplantation

Gut
Gastroenterology
2002English

Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe

Journal of Personalized Medicine
Medicine
2015English

Serum Exosomal microRNAs Combined With Alpha-Fetoprotein as Diagnostic Markers of Hepatocellular Carcinoma

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2018English

Gene Therapy for Hepatocellular Carcinoma.

SEIBUTSU BUTSURI KAGAKU
2000English

Modulation of miR-29 Expression by Alpha-Fetoprotein Is Linked to the Hepatocellular Carcinoma Epigenome

Hepatology
MedicineHepatology
2014English

Targeted Therapy in Hepatocellular Carcinoma

International Journal of Hepatology
Hepatology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy